Advertisement

Topics

The Aurora Funds, Inc. Company Profile

02:30 EDT 23rd June 2018 | BioPortfolio

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential.
Aurora’s investment team has the experience, strategic relationships and capital to help companies accelerate their growth and gain a strong competitive advantage in their market space. Since its founding in 1994, Aurora has invested in over 60 portfolio companies, resulting in five IPOs and eight M&A transactions.

Location

2525 Meridian ParkwaySuite 220
Durham
North Carolina
27713
United States of America

Contact

Phone: (919) 484-0400
Fax: (919) 484-0444
Email: afinfo@aurorafunds.com


News Articles [378 Associated News Articles listed on BioPortfolio]

Aurora Stock: What to Expect from the Aurora-CanniMed Ceasefire

Here's Why Aurora Stock May Survive the Volatility A simple case of acquisition has turned two marijuana companies-Aurora Cannabis Inc. (TSE: ACB), (OCTMKTS: ACBFF) and CanniMed Therapeutics Inc. (...

Aurora Cannabis Stock Forecast: Will the Acquisitions Pay Off?

Aurora Cannabis Stock Forecast Few companies have hogged headlines in 2018 the way Aurora Cannabis Inc (OTCMKTS:ACBFF, TSE:ACB) has. Aurora has spent the majority of the year aggressively acquiring...

Aurora Stock Still Strong Following Aurora-CanniMed Deal

Aurora Cannabis Inc (OTCMKTS: ACBFF), (TSE: ACB) is one of the hottest marijuana companies on the market, and for good reason. The company has seen massive growth over the past year and has vaulted...

Aurora Cannabis Welcomes Royal Assent of Canada's Cannabis Act

EDMONTON, Alberta, June 21, 2018 /PRNewswire/ -- First G7 Country to Legalize Adult Consumer Use - Sales to Commence October 17 TSX: ACB Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB)...

Aurora Cannabis begrüßt königliche Zustimmung zum kanadischen Cannabis-Gesetz

Edmonton, Alberta (ots/PRNewswire) - Erstes der G7-Länder hat den Gebrauch von Cannabis legalisiert - das Produkt darf ab dem 17. Oktober gehandelt werden TSX: ACB Aurora Cannabis Inc. ("Aurora" od.....

CT Green Bank Now Accepts Aurora Solar's Remote Shade Reports for Rebate Approval

With this announcement, Aurora becomes the industry's most validated and widely accepted solar design software. The results of Aurora's web-based software are accurate and Read more...

Aurora Cannabis: So langsam sollte ein Ausbruch folgen!

Lieber Leser, die Aktie von Aurora Cannabis verliert weiter an Boden. Auch wenn die Cannabis Branche sich weitestgehend von der schwachen Phase zu Jahresbeginn erholt hat, kann Aurora Cannabis davo...

Is Aurora Cannabis Still a Stock to Buy in 2018?

Aurora Cannabis and its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Reg...

Drugs and Medications [0 Results]

None

PubMed Articles [68 Associated PubMed Articles listed on BioPortfolio]

Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.

Twenty five novel chemical analogs of the previously reported Aurora kinase inhibitor BPR1K653 (1-(4-(2-((5-chloro-6-phenylfuro[2,3-d]pyrimidin-4-yl)amino)ethyl)phenyl)-3-(2-((dimethylamino)methyl)phe...

Optimal allocation of HIV prevention funds for state health departments.

To estimate the optimal allocation of Centers for Disease Control and Prevention (CDC) HIV prevention funds for health departments in 52 jurisdictions, incorporating Health Resources and Services Admi...

Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.

Aurora kinases are essential for cell mitosis, amplified and overexpressed in various human malignancies. Therefore, Aurora kinases have been promising targets for anticancer therapies, which has prom...

The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes.

Heterogeneous nuclear ribonucleoprotein (hnRNP) Q1, an RNA-binding protein, has been implicated in many post-transcriptional processes, including RNA metabolism and mRNA splicing and translation. Howe...

Polymer Nanovesicle mediated delivery of MLN8237 preferentially inhibits Aurora Kinase A to target RalA and Anchorage-Independent Growth in Breast Cancer Cells.

The small GTPase RalA is a known mediator of anchorage-independent growth in cancers and differentially regulated by adhesion and Aurora Kinase A (AURKA). Inhibiting AURKA hence offers a means of spec...

Clinical Trials [48 Associated Clinical Trials listed on BioPortfolio]

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I/II trial is s...

A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer

The purpose of this trial is to study an investigational drug in patients with recurrent or non-responsive solid tumors, or cancers for which standard therapy does not exist.

Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors

RATIONALE: Aurora B/C kinase inhibitor GSK1070916A (GSK1070916A) may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is ...

A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)

The purpose of this study is to assess the safety and tolerability of MK-0457(VX-680), an Aurora kinase inhibitor, in participants with advanced solid tumors. Bioavailability of the oral f...

Companies [440 Associated Companies listed on BioPortfolio]

The Aurora Funds, Inc.

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential. Aurora’s invest...

Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes ...

Aurora Biofuels

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel gene...

Aurora Algae

Aurora Algae is a producer of high-performance, premium algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets. The company has developed the indust...

Aurora Imaging Technology Inc.

Aurora Imaging Technology Inc. is a private company based in North Andover, Mass. committed to the fight against breast cancer. Aurora strives to manufacture the highest quality a...

More Information about "The Aurora Funds, Inc." on BioPortfolio

We have published hundreds of The Aurora Funds, Inc. news stories on BioPortfolio along with dozens of The Aurora Funds, Inc. Clinical Trials and PubMed Articles about The Aurora Funds, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Aurora Funds, Inc. Companies in our database. You can also find out about relevant The Aurora Funds, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record